Wed, Aug 20, 2014, 2:06 AM EDT - U.S. Markets open in 7 hrs 24 mins

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • stu_har stu_har Dec 13, 2012 9:19 AM Flag

    Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference

    MONMOUTH JUNCTION, N.J., Dec. 13, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies for patients with high unmet need who are battling serious orphan lung diseases, today announced that the Company will be participating in the 31st Annual J.P. Morgan Healthcare Conference from January 7-10, 2013 at the Westin St. Francis Hotel in San Francisco. Will Lewis, Insmed's President and CEO, will present a corporate overview on Thursday, January 10th at 1:30 p.m. Pacific time (4:30 p.m. Eastern time).

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • by stu_har.Dec 13, 2012 9:19 AM.
      MONMOUTH JUNCTION, N.J., Dec. 13, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies for patients with high unmet need who are battling serious orphan lung diseases, today announced that the Company will be participating in the 31st Annual J.P. Morgan Healthcare Conference from January 7-10, 2013 at the Westin St. Francis Hotel in San Francisco. Will Lewis, Insmed's President and CEO, will present a corporate overview on Thursday, January 10th at 1:30 p.m. Pacific time (4:30 p.m. Eastern time).

      • 1 Reply to insm_truth_teller
      • MONMOUTH JUNCTION, N.J., Dec. 13, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies for patients with high unmet need who are battling serious orphan lung diseases, today announced that the Company will be participating in the 31st Annual J.P. Morgan Healthcare Conference from January 7-10, 2013 at the Westin St. Francis Hotel in San Francisco. Will Lewis, Insmed's President and CEO, will present a corporate overview on Thursday, January 10th at 1:30 p.m. Pacific time (4:30 p.m. Eastern time).

 
INSM
13.73+0.23(+1.70%)Aug 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.